Table 1.
Correlations between miR‐30e‐5p expression and clinicopathological parameters in squamous cell carcinoma of head and neck (SCCHN) patients
| Parameters | Number of patients | miR‐30e‐5p expression | t value | P‐value* |
|---|---|---|---|---|
| Age | ||||
| <59 | 60 | 0.512 ± 0.284 | −2.277 | 0.025 |
| ≥59 | 53 | 0.785 ± 0.881 | ||
| Gender | ||||
| Female | 8 | 0.715 ± 0.535 | 0.338 | 0.736 |
| Male | 105 | 0.634 ± 0.659 | ||
| Smoking | ||||
| Yes | 69 | 0.527 ± 0.311 | 2.352 | 0.020 |
| No | 44 | 0.817 ± 0.946 | ||
| Histological grade | ||||
| G1 + G2 | 45 | 0.602 ± 0.452 | −0.501 | 0.617 |
| G3 | 68 | 0.665 ± 0.755 | ||
| T classification | ||||
| T1 + T2 | 60 | 0.756 ± 0.808 | 20.047 | 0.043 |
| T3 + T4 | 53 | 0.509 ± 0.367 | ||
| Clinical stage | ||||
| I + II | 42 | 0.871 ± 0.930 | 3.007 | 0.003 |
| III + IV | 71 | 0.503 ± 0.342 | ||
| Lymph node metastasis | ||||
| N0 | 66 | 0.807 ± 0.796 | 3.390 | 0.001 |
| N+ | 47 | 0.405 ± 0.187 | ||
*
P < 0.05 was considered to be statistically significant (in bold and italics).